Award of treadmetrix's DHA sbir phase II medical R & D contract for "development of a clinically feasible toolset to optimize performance and mitigate falls in warfighters with lower limb trauma…

Ended Definitive Contract Awarded Last action

Contract number
W81XWH20C0104
Awardee
Awarding agency
Obligated
$1,064,754

Award facts

Opportunity
  • HQ003420R1DSB Solicitation number
Contract value 100% obligated
$1,064,753.64 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Medical Command Department of the Army, Department of Defense
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 6 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park City, UT, USA
Research
SBIR Program Phase II Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00004 · DHA sbir phase II titled "development of a clinically feasible toolset to optimize performance and mitigate falls in warfighters with lower limb trauma and/or… $0
Supplemental Agreement for work within scope P00003 · DHA sbir 20.1 direct phase II H2D-0019 $0
Supplemental Agreement for work within scope P00002 · Per section 711 of the 2019 ndaa, usamraa transferred to DHA 10/1/2022. DHA sbir 20.1 direct phase II H2D-0019 $0
Other Administrative Action P00001 · Update contractor's address to award of treadmetrix's DHA sbir phase II medical R & D contract for "development of a clinically feasible toolset to optimize… $0
Original award $1,064,754

About this award

This is a Firm Fixed Price, definitive contract awarded by the U.S. Army Medical Command (MEDCOM) to Treadmetrix, LLC, a small disadvantaged business, for the "Development of a Clinically Feasible Toolset to Optimize Performance and Mitigate Falls in Warfighters with Lower Limb Trauma and/or Loss." The $1,064,753.64 contract is part of the Small Business Innovation Research (SBIR) program's Phase II efforts and has a performance period through January 13, 2025. The contract is set aside for small businesses.

Description

Award of treadmetrix's DHA sbir phase II medical R & D contract for "development of a clinically feasible toolset to optimize performance and mitigate falls in warfighters with lower limb trauma and/or loss"

Quick answers

Who was awarded contract W81XWH20C0104?

W81XWH20C0104 was awarded to Treadmetrix, LLC by Defense Health Agency (Department of Defense) on September 14, 2020.

How much is contract W81XWH20C0104 worth?

The government has obligated $1,064,754 on W81XWH20C0104.

Which agency awarded contract W81XWH20C0104?

Defense Health Agency (Department of Defense) awarded W81XWH20C0104, with funding from Medical Command (Department of the Army).

Was contract W81XWH20C0104 competed?

The extent of competition for W81XWH20C0104 was full and open competition after exclusion of sources. The government received 6 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award